Related Experiment Video
Updated: May 27, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Reduced Cx43 gap junction plaque expression differentiates thyroid carcinomas from benign disease.
E Ashlie Darr1, Anand D Patel, Guopei Yu
1Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA.
Archives of Otolaryngology--Head & Neck Surgery
|November 23, 2011
Summary
Loss of connexin 43 (Cx43) plaque staining is significantly associated with thyroid cancer. This finding suggests Cx43 may serve as a valuable diagnostic marker for malignant thyroid disease.
Area of Science:
- Endocrinology and Oncology
- Cell Biology and Molecular Medicine
Background:
- Connexin 43 (Cx43) is a gap junction protein crucial for intercellular communication.
- Altered Cx43 expression is implicated in various cancers, but its role in thyroid malignancy requires further investigation.
Purpose of the Study:
- To evaluate the expression patterns of Cx43 in benign versus malignant thyroid tissues.
- To determine the potential of Cx43 as a diagnostic marker for thyroid cancer.
Main Methods:
- A retrospective analysis of 50 thyroidectomy specimens was conducted.
- Immunohistochemical staining for Cx43 was performed on tissue sections.
- The membrane staining pattern of Cx43 was assessed to differentiate between benign and malignant tissues.
Main Results:
- A significant loss of Cx43 plaque staining at the cellular membrane was observed in 77% of thyroid cancer specimens compared to 15% of benign specimens.
- Loss of Cx43 staining was prevalent in papillary thyroid carcinoma (100%), follicular variant of PTC (83%), and follicular carcinoma (65%).
- Benign conditions like goiter (0%) and follicular adenoma (20%) showed minimal loss of Cx43 membrane staining.
Conclusions:
- The absence of Cx43 plaque staining is strongly associated with the presence of thyroid cancer.
- Cx43 expression patterns hold potential clinical utility as a diagnostic marker for distinguishing malignant thyroid disease from benign conditions.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...